Global Health Justice Partnership, Yale University, 127 Wall Street, New Haven, CT, 06511, USA.
Faculty of Medicine and Health, Sydney Health Ethics Level 1, Medical Foundation Building, K25, The University of Sydney, Sydney, NSW, 2006, Australia.
J Bioeth Inq. 2018 Dec;15(4):579-587. doi: 10.1007/s11673-018-9876-3. Epub 2018 Aug 16.
In April 2018, the International Association of Athletics Federations (IAAF) released new regulations placing a ceiling on women athletes' natural testosterone levels to "ensure fair and meaningful competition." The regulations revise previous ones with the same intent. They require women with higher natural levels of testosterone and androgen sensitivity who compete in a set of "restricted" events to lower their testosterone levels to below a designated threshold. If they do not lower their testosterone, women may compete in the male category, in an intersex category, at the national level, or in unrestricted events. Women may also challenge the regulation, whether or not they have lowered their testosterone, or quit sport. Irrespective of IAAF's stated aims, the options forced by the new regulations are impossible choices. They violate dignity, threaten privacy, and mete out both suspicion and judgement on the sex and gender identity of the athletes regulated.
2018 年 4 月,国际田径联合会(IAAF)发布了新规定,对女性运动员的自然睾酮水平设定上限,以“确保公平和有意义的竞争”。这些规定修订了之前具有相同意图的规定。它们要求在一系列“受限”项目中具有较高自然睾酮和雄激素敏感性的女性运动员将其睾酮水平降低到指定阈值以下。如果她们不降低睾酮水平,她们可以在男性类别、双性别类别、国家级别或非受限项目中比赛。女性也可以对该规定提出质疑,无论她们是否降低了睾酮水平,或者是否退出运动。无论国际田联的声明目的如何,新规定所规定的选择都是不可能的选择。它们侵犯了尊严,威胁到隐私,并对受监管运动员的性别和性别认同进行怀疑和评判。